enzo
biochem
report
fourth
quarter
fiscal
year
financial
results
tuesday
october
conference
call
webcast
scheduled
october
pm
et
new
york
ny
globe
newswire
enzo
biochem
nyse
enz
leading
biosciences
diagnostics
company
announced
today
report
fourth
quarter
fiscal
year
financial
results
tuesday
october
market
close
announcement
followed
live
audio
webcast
conference
call
pm
eastern
time
tuesday
october
et
domestic
international
conference
id
webcast
http
enzo
biochem
enzo
biochem
pioneer
molecular
diagnostics
leading
convergence
clinical
laboratories
life
sciences
intellectual
property
development
unique
diagnostic
platform
technologies
provide
numerous
advantages
previous
standards
global
company
enzo
biochem
utilizes
teams
develop
deploy
products
systems
services
meet
rapidly
growing
needs
health
care
today
future
underpinning
enzo
biochem
products
technologies
broad
deep
intellectual
property
portfolio
patent
coverage
across
number
key
enabling
technologies
statements
except
historical
information
matters
discussed
release
may
considered
statements
within
meaning
section
securities
act
amended
section
securities
exchange
act
amended
statements
include
declarations
regarding
intent
belief
current
expectations
company
management
including
related
cash
flow
gross
margins
revenues
expenses
dependent
number
factors
outside
control
company
including
inter
alia
markets
company
products
services
costs
goods
services
expenses
government
regulations
litigation
general
business
conditions
see
risk
factors
company
form
fiscal
year
ended
july
investors
cautioned
statements
guarantees
future
performance
involve
number
risks
uncertainties
could
materially
affect
actual
results
company
disclaims
obligations
update
statement
result
developments
occurring
date
release
contact
enzo
biochem
david
bench
cfo
dbench
media
lynn
granito
berry
company
public
relations
lgranito
investors
jeremy
feffer
lifesci
advisors
llc
jeremy
